Bionaut Labs is a venture-backed biotechnology company at the forefront of developing 'bionauts' – proprietary, remote-controlled micro-scale robots. These innovative devices are designed to navigate through the human body to deliver therapeutic payloads locally and precisely to hard-to-reach disease targets. The company's initial focus is on treating debilitating brain and central nervous system (CNS) disorders, such as Parkinson's disease, Huntington's disease, Dandy-Walker Syndrome, and malignant gliomas, where traditional treatment methods face significant limitations.
The headquarters serves as the central hub for all company operations, including pioneering research and development of bionaut technology, advanced engineering, preclinical studies, clinical program management, corporate strategy, and administrative functions.
The facility houses state-of-the-art, custom-designed laboratories specifically equipped for micro-robotics research, magnetic guidance system development, cell biology, formulation science, and includes vivarium facilities for essential preclinical testing. It also features collaborative workspaces designed to foster innovation.
Bionaut Labs fosters a dynamic, fast-paced, and mission-driven work environment. The culture emphasizes scientific rigor, engineering excellence, cross-functional collaboration, and a shared commitment to developing transformative therapies for patients with severe unmet medical needs.
The Culver City headquarters is critical to Bionaut Labs' mission, serving as the epicenter for its groundbreaking R&D activities where the bionaut platform is conceived, engineered, refined, and validated before moving into clinical development.
Bionaut Labs is currently focused on pioneering research, development, and preclinical activities primarily within the United States. The company's therapeutic ambitions are global, with a long-term vision to bring its bionaut platform to patients worldwide. Future expansion plans may include establishing international clinical trial sites and forming strategic partnerships to support global development and commercialization efforts.
10101 W Jefferson Blvd
Culver City
CA
USA
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Bionaut Labs' leadership includes:
Bionaut Labs has been backed by several prominent investors over the years, including:
Over the past year, Bionaut Labs has significantly strengthened its leadership team by appointing experienced executives to key roles in clinical operations and finance. These strategic hires are aimed at advancing the company's therapeutic programs towards clinical trials and supporting its operational growth. No executive departures have been publicly announced during this period.
Discover the tools Bionaut Labs uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Bionaut Labs commonly uses a standard corporate email format, typically combining an employee's first name and last name, or first initial and last name, with the company domain. The most frequently observed format is 'first.last@bionautlabs.com'.
first.last@bionautlabs.com
Format
michael.shpigelmacher@bionautlabs.com
Example
90%
Success rate
Fierce Biotech • February 7, 2024
Bionaut Labs reported significant preclinical achievements for its BNL-201 microrobots. The study demonstrated successful navigation to a targeted brain region and delivery of a therapeutic agent in a model of Dandy-Walker syndrome, a rare pediatric brain malformation, underscoring the platform's potential for precise, localized treatment....more
Business Wire • November 2, 2023
At the Child Neurology Society (CNS) 2023 Annual Meeting, Bionaut Labs presented compelling preclinical data on BNL-201, its lead bionaut candidate for Dandy-Walker Syndrome. The findings highlighted the therapeutic potential, precision targeting, and safety profile of BNL-201 in animal models of this rare neurological disorder....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Bionaut Labs, are just a search away.